We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGP
176
DELISTED
GGP Inc.
GGP
$644M 0.14%
21,579,898
+3,824,440
+22% +$108M
NWSA icon
177
News Corp Class A
NWSA
$15.4B
$640M 0.14%
56,429,679
+7,090,080
+14% +$85.4M
JNPR
178
DELISTED
Juniper Networks
JNPR
$640M 0.14%
28,455,384
-8,749,830
-24% -$204M
REGN icon
179
Regeneron Pharmaceuticals
REGN
$82.9B
$634M 0.13%
1,815,993
-2,203,784
-55% -$849M
ILMN icon
180
Illumina
ILMN
$29.1B
$631M 0.13%
4,617,946
+1,043,573
+29% +$148M
RPM icon
181
RPM International
RPM
$14.9B
$629M 0.13%
12,596,085
-81,810
-0.6% -$4.1M
BRK.B icon
182
Berkshire Hathaway Class B
BRK.B
$1.11T
$627M 0.13%
4,330,575
+30,411
+0.7% +$4.35M
WDAY icon
183
Workday
WDAY
$44.6B
$619M 0.13%
8,294,522
+1,496,006
+22% +$114M
WAB icon
184
Wabtec
WAB
$50.1B
$617M 0.13%
8,787,362
-5,742,475
-40% -$446M
NKE icon
185
Nike
NKE
$60.9B
$612M 0.13%
11,085,224
-15,299,404
-58% -$872M
FLS icon
186
Flowserve
FLS
$10.2B
$608M 0.13%
13,470,471
-4,926,445
-27% -$231M
ADM icon
187
Archer Daniels Midland
ADM
$38.6B
$607M 0.13%
14,161,166
-481,770
-3% -$19.2M
JBHT icon
188
JB Hunt Transport Services
JBHT
$24.8B
$599M 0.13%
7,400,295
-761,923
-9% -$62.9M
CHTR icon
189
Charter Communications
CHTR
$18.7B
$598M 0.13%
2,613,626
+2,570,733
+5,993% +$552M
MAC icon
190
Macerich
MAC
$6.94B
$597M 0.13%
6,993,085
+678,300
+11% +$53.1M
WDC icon
191
Western Digital
WDC
$151B
$592M 0.13%
16,577,572
-5,340,539
-24% -$176M
AVB icon
192
AvalonBay Communities
AVB
$26.1B
$578M 0.12%
3,204,896
-85,394
-3% -$15.4M
THS
193
DELISTED
Treehouse Foods
THS
$572M 0.12%
5,575,710
+37,743
+0.7% +$3.48M
ALK icon
194
Alaska Air
ALK
$5.43B
$567M 0.12%
9,730,929
+483,293
+5% +$33.4M
AVGO icon
195
Broadcom
AVGO
$1.97T
$566M 0.12%
36,427,030
-364,100
-1% -$5.55M
MIK
196
DELISTED
Michaels Stores, Inc
MIK
$564M 0.12%
19,832,383
+2,219,160
+13% +$62.7M
RACE icon
197
Ferrari
RACE
$72B
$562M 0.12%
13,728,024
-441,839
-3% -$18.8M
MNK
198
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$562M 0.12%
9,239,218
-3,599,928
-28% -$220M
BG icon
199
Bunge Global
BG
$21.5B
$561M 0.12%
9,488,412
+3,420,566
+56% +$209M
VRSK icon
200
Verisk Analytics
VRSK
$23.4B
$560M 0.12%
6,906,204
+33,424
+0.5% +$2.62M

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.